Beam Therapeutics, Inc. (BEAM)
22.85
-1.18
(-4.91%)
USD |
NASDAQ |
Nov 13, 16:00
22.99
+0.14
(+0.61%)
After-Hours: 19:59
Beam Therapeutics Total Assets (Quarterly) : 1.269B for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 1.269B |
| June 30, 2026 | 1.386B |
| March 31, 2026 | 1.481B |
| December 31, 2025 | 1.481B |
| September 30, 2025 | 1.311B |
| June 30, 2025 | 1.391B |
| March 31, 2025 | 1.467B |
| December 31, 2024 | 1.104B |
| September 30, 2024 | 1.171B |
| June 30, 2024 | 1.261B |
| March 31, 2024 | 1.360B |
| December 31, 2023 | 1.460B |
| September 30, 2023 | 1.291B |
| June 30, 2023 | 1.354B |
| March 31, 2023 | 1.332B |
| December 31, 2022 | 1.342B |
| Date | Value |
|---|---|
| September 30, 2022 | 1.350B |
| June 30, 2022 | 1.418B |
| March 31, 2022 | 1.453B |
| December 31, 2021 | 1.474B |
| September 30, 2021 | 1.157B |
| June 30, 2021 | 893.08M |
| March 31, 2021 | 693.24M |
| December 31, 2020 | 451.68M |
| September 30, 2020 | 278.27M |
| June 30, 2020 | 299.98M |
| March 31, 2020 | 322.64M |
| December 31, 2019 | 156.10M |
| September 30, 2019 | 170.55M |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | 167.01M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 902.56M |
| Twist Bioscience Corp. | -- |
| Prime Medicine, Inc. | 249.04M |
| Sarepta Therapeutics, Inc. | 3.166B |
| Q32 Bio, Inc. | 297.20M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 316.40M |
| Shareholders Equity (Quarterly) | 952.67M |
| Debt to Equity Ratio | 0.256 |
| Current Ratio | 13.00 |
| Net Debt Paydown Yield | -0.70% |